“Impact of Severity and Disease Course on Baricitinib Treatment Response in Adolescent Patients with Severe AA from the BRAVE-AA-PEDS Trial”. (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s665. doi:10.25251/0fqz5v46.